AEON Biopharma, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AEON NYSE American 2836 www.aeonbiopharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AEON Biopharma, Inc.

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - May 23rd, 2025 2:05 pm
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - May 19th, 2025 2:05 pm
AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - May 14th, 2025 2:05 pm
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - Apr 25th, 2025 2:05 pm
AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer - Apr 21st, 2025 2:05 pm
AEON Biopharma Announces CEO Transition - Mar 27th, 2025 2:05 pm
AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - Mar 24th, 2025 2:05 pm
AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference - Mar 4th, 2025 6:00 am
AEON Biopharma, Inc. Announces Reverse Stock Split - Feb 24th, 2025 12:00 pm
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - Feb 7th, 2025 2:05 pm
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - Jan 7th, 2025 7:37 am
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering - Jan 6th, 2025 7:00 am
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering - Jan 3rd, 2025 6:02 pm
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Nov 13th, 2024 2:05 pm
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting - Sep 30th, 2024 6:00 am
AEON Biopharma, Inc. (AEON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Aug 21st, 2024 7:55 am
AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - Aug 19th, 2024 2:05 pm
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - Aug 12th, 2024 2:05 pm
AEON Biopharma Announces Strategic Reprioritization to Pursue a Biosimilar Pathway for ABP-450 - Jul 9th, 2024 6:00 am